UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000019598
Receipt No. R000022653
Official scientific title of the study Effect of Leucine-rich essential amino acid mixture food (amino care jelly Leucine 40) on exercise therapy in NAFLD (Pilot Trial)
Date of disclosure of the study information 2015/12/01
Last modified on 2018/02/01 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of Leucine-rich essential amino acid mixture food (amino care jelly Leucine 40) on exercise therapy in NAFLD (Pilot Trial)
Title of the study (Brief title) Amino L40 Trial
Region
Japan

Condition
Condition Non-alcoholic fatty liver disease
Classification by specialty
Gastroenterology Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This pilot trial aims to evaluate of effect of intake of "amino care jelly Leucine 40" after exercise therapy on improvements in skeletal muscle tissue fat accumulation and glucose metabolism in NAFLD
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Longitudinal change in skeletal muscle tissue fat accumulation by IMAC
Key secondary outcomes Skeletal muscle volume, insulin resistance, liver function, serum lipid, glucose metabolism, inflammatory markers, and each parameter

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 (1) Diet and exercise therapy (+)
amino care jelly Leucine 40 (-)
0 - 12 weeks
(2) Diet and exercise therapy (+)
amino care jelly Leucine 40 (100g / day) (+)
12 - 24 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
50 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria (1) Cases were clinically diagnosed as NAFLD
(2) More than 50 years of age and less than 80 years
(3) Informed consent is obtained by sentence
Key exclusion criteria (1) Patients with viral hepatitis
(2) Liver cirrhosis patients
(3) Patients with malignant tumor (not included after radical)
(4) Individuals with a history of cardiovascular or cerebrovascular Diseases
(5) Severe liver disease
(6) Severe renal disease
(7) Patients with rush by "amino care jelly Leucine 40"
Target sample size 20

Research contact person
Name of lead principal investigator Yuichiro Eguchi
Organization Faculty of Medicine, Saga University
Division name Division of Hepatology
Address 5-1-1 Nabeshima,Saga City, Saga Prefecture, Japan
TEL 0952-34-2362
Email eguchiyu@cc.saga-u.ac.jp

Public contact
Name of contact person Hirokazu Takahashi
Organization Faculty of Medicine, Saga University
Division name Department of Internal Medicine
Address 5-1-1 Nabeshima,Saga City, Saga Prefecture, Japan
TEL 0952-34-2362
Homepage URL
Email takahas2@cc.saga-u.ac.jp

Sponsor
Institute Faculty of Medicine, Saga University
Institute
Department

Funding Source
Organization Faculty of Medicine, Saga University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Eguchi Hospital
Name of secondary funder(s) Ajinomoto Co.,Ltd.

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 佐賀大学医学部(佐賀県)

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 01 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 09 Month 11 Day
Anticipated trial start date
2015 Year 12 Month 01 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 11 Month 02 Day
Last modified on
2018 Year 02 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022653